Fernanda Nicolela Susanna

Fernanda Nicolela Susanna

Auto-generated profile, based on publicly available information

Fernanda Nicolela Susanna

Ophthalmology Department of University of São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2020 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
FSFernanda Nicolela Susanna
Fernanda Nicolela Susanna
CPCarlos Pavesio
Carlos Pavesio
The recent introduction of biological agents has revolutionized the treatment of chronic immune-inflammatory diseases; however, this new therapy did not come without significant side effects.Through large controlled studies indicating decrease in the number of uveitis flares, the role of TNF inhibitors therapy for non-infectious uveitis gained more ground. Paradoxically to its therapeutic effect, there are reports associating these drugs with the onset or recurrence of inflammatory eye disease.A number of studies have suggested possible roles for anti-TNF-α agents in precipitating or worsening an underlying inflammatory process, including the hypothesis of a disequilibrium in cytokine balance, but to date the mechanisms responsible for these adverse events are not fully understood.A PubMed literature search was performed using the following terms: ophthalmic complication, uveitis, inflammatory eye disease, optic neuritis, neuropathy, adverse events, anti-TNF, TNF alpha inhibitor, infliximab, etanercept, adalimumab, golimumab, certolizumab, and biologics. The data presented in this study was mainly derived from the use of TNF inhibitors in rheumatology, essentially because these drugs have been used for a longer period in this medical field.Many of the ocular adverse events reported on this review may be considered a paradoxical effect of anti-TNF therapy. We found a variety of data associating new onset of uveitis with anti-TNF therapy for rheumatic conditions, predominantly under etanercept.In conclusion, although there is increasing data on ocular adverse events, it remains to be seen whether the suggested link between TNF inhibitors and the onset of ocular inflammation is substantiated by more quality data. Nevertheless, the awareness of potential treatment side effects with anti-TNF should be highlighted.

1 January 2021 in Clinics
Verified
Journal Article
Open access
DCDouglas Rodrigues da Costa
Douglas Rodrigues da Costa
IDIara Debert
Iara Debert
FSFernanda Nicolela Susanna
Fernanda Nicolela Susanna
JFJanaina Guerra Falabreti
Janaina Guerra Falabreti
MPMariza Polati
Mariza Polati
RSRemo Susanna
Remo Susanna
Uncorrected refractive errors are the leading cause of visual impairment in children. In this cross-sectional retrospective study, we analyzed a social visual screening program for school children in São Paulo, Brazil, evaluated its impact on ...

15 September 2021 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
DCDouglas Rodrigues da Costa
Douglas Rodrigues da Costa
RFRodrigo Dahia Fernandes
Rodrigo Dahia Fernandes
FSFernanda Nicolela Susanna
Fernanda Nicolela Susanna
ENEpitácio Dias da Silva Neto
Epitácio Dias da Silva Neto
MMMario Monteiro
Mario Monteiro
Background: Leukemic involvement of the eyes is rare, therefore, treatment relies on previous case reports. The treatment of ocular complications poses additional difficulties, because the eye is considered as a pharmacological “sanctuary” for patients with acute lymphoblastic leukemia (ALL). Therefore, radiotherapy is the main therapeutic choice; however, it might lead to many important side effects. To the best of our knowledge, this is the first case report of a bilateral leukemic optic nerve infiltration that remitted with chemotherapy without adjuvant radiotherapy. Case presentation: A 30-year-old female patient with previous history of remitted ALL presented with a one-week history of floaters in her right eye. Her ophthalmological exam showed remarkable optic disc swelling, in both eyes. She was diagnosed with ALL relapse presenting as a bilateral optic nerve leukemic infiltration. Local radiotherapy was planned for both eyes, however, due to efficient recovery with chemotherapy, it was cancelled. Allogenic bone marrow transplantation was subsequently performed. The patient is being followed up and ALL remitted. Conclusion: Leukemia relapse on central nervous system, despite rare, is a sign of poor prognosis and requires prompt treatment. Its occurrence on ocular tissues is even rarer. It is hypothesized that the blood-brain barrier limits the delivery of chemotherapeutic drugs to the eye and infiltration of the optic nerve by leukemic cells might prejudice the flow of cerebrospinal fluid between the cranial space and the optic disc.

1 November 2021 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
FSFernanda N. Susanna
Fernanda N. Susanna
BMBruna Melchior
Bruna Melchior
JPJayter S. Paula
Jayter S. Paula
MBMichael V. Boland
Michael V. Boland
JMJonathan S. Myers
Jonathan S. Myers
CMCarlos Gustavo De Moraes
Carlos Gustavo De Moraes

16 December 2024 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
FSFernanda Nicolela Susanna
Fernanda Nicolela Susanna
CSCarolina Nicolela Susanna
Carolina Nicolela Susanna
PLPedro Gabriel Salomão Libânio
Pedro Gabriel Salomão Libânio
FNFernanda Tiemi Nishikawa
Fernanda Tiemi Nishikawa
RGRenato Antunes Schiave Germano
Renato Antunes Schiave Germano
RJRemo Susanna Junior
Remo Susanna Junior

16 December 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
BSBianca N Susanna
Bianca N Susanna
AFAdriana S ForsetoMD
Adriana S ForsetoMD
ASAline M SilveiraMD
Aline M SilveiraMD
MSMarcony R Santhiago
Marcony R Santhiago
FSFernanda N Susanna
Fernanda N Susanna
NPNicolas C Pereira
Nicolas C Pereira
Purpose: To investigate the effectiveness and safety of customized femtosecond laser-assisted corneal allogenic intrastromal ring segments (CAIRS) implantation in keratoconus patients with a history of intrastromal corneal ring segment (ICRS) explantation. Setting: Sorocaba Eye Hospital (Hospital Oftalmológico de Sorocaba - HOS), Sorocaba, Brazil. Design: Prospective case series. Methods: We included eight keratoconus patients with stable disease and with history of ICRS explantation at least six months before the inclusion in the study. Patients were excluded if presenting any other ocular pathology. Customized CAIRS was produced and implanted using femtosecond laser LDV Z8 (Ziemer Ophthalmic Systems AG, Port, Switzerland). Patients were followed-up for six months. Results: The mean reduction of the maximum, mean, and steep central keratometry was 3.03 ± 1.35 diopters (D) (p =0.01), 2.88 ± 2.51 D (p=0.02), and 2.41 ± 2.72 D (p=0.04), respectively. The mean spherical equivalent and refractive astigmatism reduced 6.28 ± 2.71 D (p =0.01), and 1.62 ± 2.83 D (p=0.16). All eyes, but one gained two or more lines of best spectacle corrected visual acuity (BSCVA). Additionally, five patients achieved a BSCVA of 20/40 or better. No intra or post-operative complications were observed. Conclusions: Customized femtosecond laser assisted CAIRS may be an effective and safe option for visual rehabilitation in keratoconus patients with previous ICRS explantation.